Interim Relief For PARI Pharma In Bid To Stop EMA From Releasing Data
This article was originally published in SRA
Executive Summary
The EU General Court has temporarily barred the European Medicines Agency from giving Novartis access to certain data about a rival firm's product under the agency's access to documents policy1.